Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TONOLLA, E. H.
Right arrow Articles by BRANTIGAN, O. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by TONOLLA, E. H.
Right arrow Articles by BRANTIGAN, O. C.
(Chest. 1947;13:123-132.)
© 1947 American College of Chest Physicians

Treatment of Thoracic Empyema with Sodium Tetradecyl Sulfate 1:500 in Azochloramid 1:3300

E. H. TONOLLA M.D. and O. C. BRANTIGAN M.D.

1. No chemotherapeutic agent or combination of agents will replace adequate surgical procedure and technique in the treatment of empyema.

2. Sodium tetradecyl sulfate, 1:500, in azochloramid, 1:3300, seems to be the best chemotherapeutic agent available in the treatment of acute pyogenic empyema, especially if bronchopleural fistula or mediastinal shift is present.

3. Azochloramid tetradecyl solution lowers surface tension, thereby allowing better penetration of the antiseptic agent and facilitates removal of the exudate. In addition, azochloramid tetradecyl sulfate solution tends to prevent reformation of intrapleural fluid while sterilizing the area.

4. Close attention must be given to the mechanical aspect of the pleural cavity.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1947 by the American College of Chest Physicians.